Your session is about to expire
← Back to Search
Behavioural Intervention
Virtual Reality Therapy for Spatial Neglect After Stroke (VR-SRT Trial)
N/A
Recruiting
Led By Peii Chen, PhD
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Presence of moderate to severe spatial neglect
Have a history of one stroke event that injured one cerebral hemisphere
Must not have
History of progressive neurological disorders
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two weeks after intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a virtual reality system to help people with spatial neglect, a common problem after stroke.
Who is the study for?
This trial is for English-speaking stroke survivors who have spatial neglect due to damage in one side of the brain. They should live within 50 miles of West Orange, NJ. Those with severe psychiatric or progressive neurological disorders, or a history of vestibular problems cannot participate.
What is being tested?
The study is testing a new virtual reality (VR) therapy game designed to help improve attention and awareness of space in people who experience spatial neglect following a stroke.
What are the potential side effects?
Since this is not a drug trial but involves VR technology, potential side effects may include dizziness, nausea, eye strain, or disorientation immediately after using the VR system.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have trouble noticing things on one side of my body or space.
Select...
I have had a stroke that affected one side of my brain.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a worsening neurological condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline, after intervention, and two weeks after intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, after intervention, and two weeks after intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Behavioral Inattention Test
Secondary study objectives
Semi-structured interview
Simulator Sickness Questionnaire
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: VR-based spatial retrainingExperimental Treatment1 Intervention
Game-like therapy activities will be taken place in a virtual environment, provided through an immersive head-mounted display.
Find a Location
Who is running the clinical trial?
Kessler FoundationLead Sponsor
184 Previous Clinical Trials
11,259 Total Patients Enrolled
5 Trials studying Spatial Neglect
359 Patients Enrolled for Spatial Neglect
Peii Chen, PhDPrincipal Investigator - Kessler Foundation
Kessler Foundation
3 Previous Clinical Trials
86 Total Patients Enrolled
1 Trials studying Spatial Neglect
14 Patients Enrolled for Spatial Neglect
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have trouble noticing things on one side of my body or space.I have had a stroke that affected one side of my brain.I have a worsening neurological condition.You have a history of problems with your balance or dizziness.
Research Study Groups:
This trial has the following groups:- Group 1: VR-based spatial retraining
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.